Blog
RSS FeedPosted by Michael Wonder on 28 May 2020
European medicines regulatory network fully mobilised in fight against COVID-19
28 May 2020 - The development and availability of medicines and vaccines for all patients in the European Union, including those ...
Posted by Michael Wonder on 27 May 2020
EMA commissions independent research to prepare for real world monitoring of COVID-19 vaccines
27 May 2020 - EMA is engaging early with researchers to ensure that a European infrastructure will be in place to ...
Posted by Michael Wonder on 26 May 2020
EMA calls for high-quality observational research in context of COVID-19
26 May 2020 - For observational studies of real world data in COVID-19, EMA calls for transparency for protocols and results, ...
Posted by Michael Wonder on 21 May 2020
EMA extends virtual-only meeting policy through August
20 May 2020 - The EMA has announced it is extending its decision to hold all upcoming meetings virtually through ...
Posted by Michael Wonder on 20 May 2020
Global regulators commit to cooperate on observational research in the context of COVID-19
20 May 2020 - Regulators from around the world have agreed three priority areas for cooperation on observational research during ...
Posted by Michael Wonder on 20 May 2020
Europe falls behind U.S. in funding coronavirus vaccine and securing access
19 May 2020 - U.S. was faster in shouldering drug companies’ costs to develop and manufacture vaccine candidates, putting the bloc ...
Posted by Michael Wonder on 19 May 2020
Top pharma official rejects idea of free COVID-19 vaccine for all
18 May 2020 - A leading representative of the pharmaceutical industry has downplayed the idea of a vaccine against the ...
Posted by Michael Wonder on 18 May 2020
EMA may conditionally authorise remdesivir in the ‘coming days’
18 May 2020 - The EMA's Executive Director Guido Rasi on Monday told a European Parliament committee that the agency ...
Posted by Michael Wonder on 18 May 2020
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #2
18 May 2020 - The International Coalition of Medicines Regulatory Authorities (ICMRA) convened a virtual meeting of regulators from around ...
Posted by Michael Wonder on 18 May 2020
EU actions to support availability of medicines during COVID-19 pandemic – update #6
15 May 2020 - The EU Executive Steering Group on Shortages of Medicines Caused by Major Events held a virtual ...
Posted by Michael Wonder on 15 May 2020
International coordination needed to encourage conduct of large, decision-relevant COVID-19 clinical trials
15 May 2020 - Regulators are highlighting the need for a comprehensive international coordination mechanism to allow the conduct of ...
Posted by Michael Wonder on 14 May 2020
Coronavirus vaccine could be ready in a year: EU medicine agency
14 May 2020 - A vaccine to counter the new coronavirus could be approved in about a year in an ...
Posted by Michael Wonder on 11 May 2020
EMA recommends expanding remdesivir compassionate use to patients not on mechanical ventilation
11 May 2020 - EMA’s human medicines committee (CHMP) has recommended expanding the compassionate use of the investigational medicine remdesivir ...
Posted by Michael Wonder on 08 May 2020
EU actions to support availability of medicines during COVID-19 pandemic – update #5
8 May 2020 - The EU Executive Steering Group on Shortages of Medicines Caused by Major Events held a virtual ...
Posted by Michael Wonder on 05 May 2020
World leaders donate to COVID-19 vaccine funding drive
5 May 2020 - Experts says $20 billion needed to vaccinate global population. ...